Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02655380
Other study ID # MED-DRU-15-354
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date June 19, 2017
Est. completion date April 16, 2018

Study information

Verified date January 2019
Source Ajou University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Ketamine and opioid are known to improve the intubating condition, respectively. Combination of ketamine and opioid potentiate analgesic effect and give hemodynamic stability in complementary manner. Therefore, the combination use of ketamine and remifentanil could be useful for acceptable intubating condition in the general anesthesia without the use of neuromuscular blocking agent. Generally, induction dose of ketamine ranges between 1 and 2 mg. There was no report about the optimal dose of remifentanil with 1 or 2 mg ketamine induction dose for intubation without neuromuscular blocking agent. The investigators focus on remifentanil dose using Dixon's up and down method.


Recruitment information / eligibility

Status Completed
Enrollment 51
Est. completion date April 16, 2018
Est. primary completion date April 16, 2018
Accepts healthy volunteers No
Gender All
Age group 3 Years to 12 Years
Eligibility Inclusion Criteria:

- ASA I-II

- Undergoing general anesthesia with endotracheal tube

Exclusion Criteria:

- Anticipated difficult airway

- Patient with upper respiratory infection within 14 days

- Asthma

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ketamine 1
Anesthesia induction is performed with 1 mg ketamine.
Ketamine 2
Anesthesia induction is performed with 2 mg ketamine.
Remifentanil
After anesthesia induction with ketamine, predetermined remifentanil using Dixon's up and dowm method is administered.

Locations

Country Name City State
Korea, Republic of Ajou universitiy school of medicine Suwon-si Gyeong-gi Do

Sponsors (1)

Lead Sponsor Collaborator
Ajou University School of Medicine

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary acceptability of intubation condition For assessment of intubation condition, 5 variables will be individually evaluated though 3 point scale (excellent, good, poor). If all variables are graded as excellent, intubation condition will be excellent. If at least 1 variable is poor, it will be reported as poor. Otherwise, it will be reported as good. Good and excellent will be considered to be acceptable intubating condition. Poor will be reported as unacceptable intubating condition.
Laryngoscope easiness
Vocal cord position
Vocal cord movement
Movement of limb
Coughing
during and after intubation, about 2 minute
See also
  Status Clinical Trial Phase
Completed NCT01479751 - Comparison of Methods to Facilitate Rapid Sequence Intubation N/A